tiprankstipranks
Trending News
More News >
Biofrontera AG (DE:B8FK)
XETRA:B8FK
Germany Market

Biofrontera (B8FK) Income Statement

Compare
3 Followers

Biofrontera Income Statement

Last quarter (Q4 2023), Biofrontera's total revenue was €7.45M, an increase of 28.47% from the same quarter last year. In Q4, Biofrontera's net income was €5.92M. See Biofrontera’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
€ 32.25M€ 25.74M€ 28.79M€ 30.35M€ 31.27M
Gross Profit
€ 25.37M€ 20.98M€ 24.87M€ 26.81M€ 26.39M
Operating Expenses
€ 20.59M€ 19.39M€ 60.21M€ 36.84M€ 49.77M
Depreciation and Amortization
€ 791.00K€ 746.00K€ 3.29M€ 5.33M€ 3.16M
EBITDA
€ 5.57M€ 2.34M€ -12.59M€ -277.00K€ -20.22M
Operating Income
€ 4.78M€ 1.59M€ -15.88M€ -5.61M€ -2.07M
Other Income/Expenses
€ 356.00K€ -44.80M€ 51.56M€ -7.09M€ 18.60M
Pretax Income
€ 5.14M€ -43.21M€ 35.68M€ -12.70M€ -4.78M
Net Income
€ -369.00K€ -44.17M€ 37.75M€ -13.02M€ -7.36M
Per Share Metrics
Basic EPS
€ -0.01€ -0.77€ 0.66€ -0.22€ -0.15
Diluted EPS
€ -0.01€ -0.77€ 0.65€ -0.22€ -0.15
Weighted Average Shares Outstanding
63.81M 57.47M 57.90M 58.18M 47.99M
Weighted Average Shares Outstanding (Diluted)
63.81M 57.47M 59.29M 58.18M 47.99M
Currency in EUR

Biofrontera Earnings and Revenue History